Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Mechanical Stress-Induced Autophagy and Cytoskeletal Control
2026-09-17
The reference study shows that autophagy triggered by compressive force depends primarily on cytoskeletal microfilaments, while microtubules provide an auxiliary contribution. By combining cytoskeletal polymerization modulators with fluorescence imaging and western blotting, the work connects cellular mechanical properties to autophagosome responses and provides a framework for studying mechanotransduction.
-
Atrial Natriuretic Peptide: Workflow & Applications
2026-09-16
Build reproducible cardiovascular assays around a research-grade ANP peptide hormone, from formulation and dose-response design to vascular, renal, and adipose endpoints. The workflow also shows how to use the reference study as a complementary neuroinflammation model without overstating evidence for ANP itself.
-
Tigecycline Workflows for MDR Bacterial Research
2026-09-16
Build reproducible susceptibility, time-kill, and resistance-surveillance workflows with Tigecycline, a glycylcycline antibiotic suited to challenging bacterial panels. This guide connects phenotypic testing with plasmid-transmission analysis while highlighting formulation, endpoint, and interpretation controls.
-
Acetylspiramycin in Resistance Assays
2026-09-15
Acetylspiramycin (Spiramycin B) gives researchers a 16-membered macrolide comparator for ribosome-focused susceptibility testing, especially when erythromycin and azithromycin resistance complicates interpretation. This guide converts recent Mycoplasma pneumoniae findings into practical broth microdilution, resistance-monitoring, and host–pathogen workflows.
-
Sulforaphane, ROS, and NLRP3 in Experimental Colitis
2026-09-15
A 2024 Biomedicine & Pharmacotherapy study investigated how Sulforaphane reduces dextran sodium sulfate-induced colitis by lowering reactive oxygen species and suppressing NLRP3 inflammasome signaling. By combining mouse experiments with RAW264.7 macrophage studies, the work provides a mechanistic framework for examining redox-sensitive inflammation in ulcerative colitis research.
-
Mitochondrial CAT-Tailing Drives Glioblastoma Growth
2026-09-14
The reference study identifies mitochondrial stress-induced carboxyl-terminal alanine and threonine tailing as a functional ribosome-associated quality-control response that supports glioblastoma survival. By linking CAT-tailed ATP5α to membrane-potential maintenance, permeability-transition control, apoptosis resistance, and migration, the work suggests a mechanistic connection between translational stress and tumor progression.
-
4-MUG Workflows for Lysosomal Enzyme Assays
2026-09-14
4-Methylumbelliferyl-β-D-Glucopyranoside converts β-glucosidase and β-glucocerebrosidase activity into a sensitive fluorescent readout for lysosomal studies, Gaucher disease models, and screening. This practical guide explains assay setup, mRNA-therapy workflows, optimization choices, and troubleshooting for reproducible 4-MUG measurements.
-
Necrosulfonamide: Mapping Necroptosis to Translation
2026-09-13
Necrosulfonamide provides a pathway-positioned way to test whether MLKL membrane execution links upstream stress biology to translational injury. This article interprets recent cardiac microvascular ischemia–reperfusion findings and offers a practical framework for using NSA in mechanistic, cancer, and exploratory neurodegenerative disease models.
-
COX-2, Ischemia, and Muscle Revascularization
2026-09-12
This study shows that COX-2 has a time-dependent role after Bothrops asper venom injury: it protects muscle microvessels during acute ischemia, yet its early inhibition later enhances proangiogenic and matrix-remodeling signals. The findings refine how selective COX-2 inhibition should be interpreted in muscle injury and revascularization models.
-
Leptin (116-130), amide, mouse Workflows
2026-09-11
Use this defined leptin fragment to build controlled assays for energy balance, obesity, diabetes, and immunometabolic signaling. Practical preparation guidance, comparative assay design, and a cautious SIRT6–AMPK–NLRP3 extension help distinguish direct peptide effects from context-dependent leptin resistance.
-
A-1210477: Mapping MCL-1-Dependent Apoptosis
2026-09-11
A-1210477 is a selective MCL-1 inhibitor for distinguishing target engagement from genuine apoptotic dependence. This article develops an evidence-driven framework for mitochondrial apoptosis assay design, mechanistic validation, combination studies, and translational interpretation.
-
FGFR2 Fusion ICC: HDO and Asparagine Depletion
2026-09-10
The reference study develops a cholesterol-conjugated DNA/RNA heteroduplex oligonucleotide that selectively suppresses the FGFR2-AHCYL1 fusion in intrahepatic cholangiocarcinoma. It also identifies an EGFR–STAT1–ASNS adaptation pathway and shows why asparagine depletion may improve responses to fusion-directed treatment in preclinical models.
-
HyperScript First-Strand cDNA Synthesis Kit Workflow
2026-09-10
Translate scarce, long, or structurally difficult RNA into dependable templates for PCR amplification and qPCR reaction workflows. The kit combines primer flexibility with a thermally stable, high-affinity reverse transcriptase for applications such as EV-associated lncRNA profiling and low copy gene reverse transcription.
-
Imidazoline Antagonists and β-Cell K+ Channels
2026-09-09
The 1992 study showed that alinidine, antazoline, phentolamine, and tolazoline enhance insulin release primarily by inhibiting ATP-sensitive K+ channels in pancreatic β-cells, rather than solely by blocking α2-adrenoceptors. Its combination of 86Rb efflux, patch-clamp, and insulin-secretion experiments provides a useful framework for separating receptor-dependent effects from direct ion-channel pharmacology.
-
PD-L1–IL-6 Crosstalk in Primary Sclerosing Cholangitis
2026-09-09
The reference study combines spatial proteomics with cell-cell cross-talk analysis to examine how immune checkpoint and cytokine signaling are organized in human primary sclerosing cholangitis. Its central contribution is the identification of a PD-L1–IL-6 interaction at the epithelial-immune interface, providing a spatially informed framework for studying persistent inflammation in the biliary tree.